Buy Stocks Easy | About Us
April 23, 2021
Buy Stocks Easy | Online Stocks

CBAY


Buy CymaBay Therapeutics Inc. Stock (symbol: CBAY) Easy Online

Company Name: CymaBay Therapeutics Inc.

Symbol: CBAY

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2014

CBAY Current Share Price

Today's CBAY ( CymaBay Therapeutics Inc. ) opening price: $1.8200

Yesterday's CBAY ( CymaBay Therapeutics Inc. ) closing price: $1.8600

CymaBay Therapeutics Inc. Stock ( symbol: CBAY ) Price Chart since IPO (2014):

12 Months CymaBay Therapeutics Inc. Stock ( symbol: CBAY ) Price Chart

Popular Questions about CymaBay Therapeutics Inc. Public Stock ( CBAY )

A: CymaBay Therapeutics Inc. stock symbol (also called stock or share ticker) is CBAY

A: CymaBay Therapeutics Inc. IPO (Initial Public Offering) took place on 2014

A: CymaBay Therapeutics Inc.'s stock (CBAY symbol) price at ther IPO (initial Public Offering) was $1.8200

Q: Is CBAY stock worth buying at the moment?

A: The CBAY stock performance since 2019 are rather disappointing. If you had bought 1 share of CymaBay Therapeutics Inc. stock (symbol: CBAY) at the beginning of 2019, at the opening share price of $8.7000, you would be left with exactly $1.8200 - which means a waste of your money and time. - SHOW ONLY IF equal or loose.

Buy CymaBay Therapeutics Inc. Stock Easy Online

CymaBay Therapeutics Inc. Stock Ticker Price Chart since IPO:





CymaBay Therapeutics Inc. Stock Price Yesterday



 


CymaBay Therapeutics Inc. Stock Price – Last Week




 


CymaBay Therapeutics Inc. Stock Price – Last Month




 


CymaBay Therapeutics Inc. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.zacks.com/stock/news/646504/nash-scorecard-year-to-date-the-winners-and-the-losers
                            

                                
NASH Scorecard Year to Date: The Winners and the Losers

                                
                                
NASH sees a highly rewarding market with candidates of blockbuster ...


                            

                        
                    

                


                            

                    


                        
                            https://www.fool.com/investing/2019/11/25/why-aurora-cannabis-kirkland-lake-gold-and-cymabay.aspx
                            

                                
Why Aurora Cannabis, Kirkland Lake Gold, and CymaBay Therapeutics Slumped Today

                                
                                
Even in a winning market, these stocks fell. Find out why.


                            

                        
                    

                


                            

                    


                        
                            https://www.marketwatch.com/story/cymabay-shares-fall-on-halted-trial-2019-11-25
                            

                                
CymaBay shares fall on halted trial

                                
                                
Shares of CymaBay Therapeutics Inc. CBAY, +6.12% are down 11% in pr...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4303008-cymabay-therapeutics-inc-cbay-ceo-sujal-shah-q3-2019-results-earnings-call-transcript
                            

                                
Cymabay Therapeutics, Inc. (CBAY) CEO Sujal Shah on Q3 2019 Results - Earnings Call Transcript

                                
                                
Cymabay Therapeutics, Inc. (CBAY) CEO Sujal Shah on Q3 2019 Results...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/28/1936164/0/en/CymaBay-Therapeutics-to-Report-Third-Quarter-2019-Financial-Results-on-Tuesday-November-5.html
                            

                                
CymaBay Therapeutics to Report Third Quarter 2019 Financial Results on Tuesday, November 5

                                
                                
NEWARK, Calif., Oct.  28, 2019  (GLOBE NEWSWIRE) -- CymaBay Therape...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/14/1929130/0/en/CymaBay-Therapeutics-to-Present-at-the-H-C-Wainwright-3rd-Annual-NASH-Investor-Conference.html
                            

                                
CymaBay Therapeutics to Present at the H.C. Wainwright 3rd Annual NASH Investor Conference

                                
                                
NEWARK, Calif., Oct.  14, 2019  (GLOBE NEWSWIRE) -- CymaBay Therape...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/646504/nash-scorecard-year-to-date-the-winners-and-the-losers
                            

                                
NASH Scorecard Year to Date: The Winners and the Losers

                                
                                
NASH sees a highly rewarding market with candidates of blockbuster ...


                            

                        
                    

                


                            

                    


                        
                            https://www.fool.com/investing/2019/11/25/why-aurora-cannabis-kirkland-lake-gold-and-cymabay.aspx
                            

                                
Why Aurora Cannabis, Kirkland Lake Gold, and CymaBay Therapeutics Slumped Today

                                
                                
Even in a winning market, these stocks fell. Find out why.


                            

                        
                    

                


                            

                    


                        
                            https://www.marketwatch.com/story/cymabay-shares-fall-on-halted-trial-2019-11-25
                            

                                
CymaBay shares fall on halted trial

                                
                                
Shares of CymaBay Therapeutics Inc. CBAY, +6.12% are down 11% in pr...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4303008-cymabay-therapeutics-inc-cbay-ceo-sujal-shah-q3-2019-results-earnings-call-transcript
                            

                                
Cymabay Therapeutics, Inc. (CBAY) CEO Sujal Shah on Q3 2019 Results - Earnings Call Transcript

                                
                                
Cymabay Therapeutics, Inc. (CBAY) CEO Sujal Shah on Q3 2019 Results...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/28/1936164/0/en/CymaBay-Therapeutics-to-Report-Third-Quarter-2019-Financial-Results-on-Tuesday-November-5.html
                            

                                
CymaBay Therapeutics to Report Third Quarter 2019 Financial Results on Tuesday, November 5

                                
                                
NEWARK, Calif., Oct.  28, 2019  (GLOBE NEWSWIRE) -- CymaBay Therape...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/14/1929130/0/en/CymaBay-Therapeutics-to-Present-at-the-H-C-Wainwright-3rd-Annual-NASH-Investor-Conference.html
                            

                                
CymaBay Therapeutics to Present at the H.C. Wainwright 3rd Annual NASH Investor Conference

                                
                                
NEWARK, Calif., Oct.  14, 2019  (GLOBE NEWSWIRE) -- CymaBay Therape...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.